Mutations in RPL22 occur at an A8 homopolymer and have been detected in 51/148 MSI ECs (35%, TCGA pan-cancer cBioportal analysis) [32], as well as 12/23 (52%) MSI ECs [34] and 17/34 MSI EC [35]. The gene discussed is RPL22; the disease is cancer.